Cycle thresholds and discordant 2-step testing for Clostridioides Difficile: Comparison of clinical characteristics and outcomes among discordant and true positive results
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 11.05.2026. Verfasst von Michael Rossi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School of Brown University, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine if Toxin B polymerase chain reaction (PCR) cycle threshold (Ct) can help identify which patients with discordant clostridioides difficile (CD) PCR and enzyme immunoassay testing (EIA) may benefit from treatment.
Design
Retrospective case series.
Setting
Multi-hospital tertiary Academic system. Patients: All admitted adult patients with positive CD PCR over a 6 month period (n = 214). Patients with positive Stool PCR for other pathogens were excluded.
Methods
Chart review of all eligible patients. CD testing results, patient demographics, underlying comorbidities, symptoms prompting testing, risk factors for CD, markers of severe disease, treatment regimens, and clinical outcomes including: 30-day all-cause mortality and re-admission, and 60-day CDI repeat testing and treatment were collected.
Results
Significant association between mortality and lower Ct values among discordant patients who were not treated compared to those who were (P = 0.042). The association between Ct values and 30-day readmission was significantly stronger among untreated patients compared to those who were treated (P = .034). A similar trend was observed among non-severe, untreated patients with low Ct values and subsequent CDI treatment within 60 days (CT < 26, 49% vs. CT > 26, 18%, P = .063).
Conclusions
Untreated patients with lower cycle thresholds had worse clinical outcomes compared to untreated patients with higher Ct, regardless of disease severity. A lower PCR Ct can support treatment in patients with clinical disease, positive PCR and negative toxin EIA.
Autor:innen und Institutionen
- Warren Alpert Medical School of Brown University, USA.
- Brown University Health, USA.
- Newport Hospital, USA.
- Rhode Island Hospital, USA.
ORCID-Profile: Michael Rossi, Tao Hong, Sara F Geffert
Zitieren
APA
Rossi, M., O'Rourke, E., Hong, T., Geffert, S. F., Chargualaf, T. L., Collins, A., Tanzer, J. R., & Touzard-Romo, F. (2026). Cycle thresholds and discordant 2-step testing for Clostridioides Difficile: Comparison of clinical characteristics and outcomes among discordant and true positive results. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10375
Vancouver
Rossi M, O'Rourke E, Hong T, Geffert SF, Chargualaf TL, Collins A, et al. Cycle thresholds and discordant 2-step testing for Clostridioides Difficile: Comparison of clinical characteristics and outcomes among discordant and true positive results. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10375
BibTeX
@article{Rossi2026,
author = {Rossi, Michael and O'Rourke, Emerald and Hong, Tao and Geffert, Sara F and Chargualaf, Tiffany L and Collins, Andrea and Tanzer, Joshua Ray and Touzard-Romo, Francine},
title = {Cycle thresholds and discordant 2-step testing for Clostridioides Difficile: Comparison of clinical characteristics and outcomes among discordant and true positive results},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10375}
}
EUVIMED